MarketCap
Facebook
X
Telegram
PetIQ Kurzfristige Verbindlichkeiten | PETQ
Kurzfristige Verbindlichkeiten Jährlich PetIQ
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 190 M | 149 M | 98.1 M | 101 M | 73 M | 64.2 M | 18.2 M | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 190 M | 18.2 M | 99.1 M |
Kurzfristige Verbindlichkeiten anderer Aktien in der Arzneimittelhersteller
| Name | Kurzfristige Verbindlichkeiten | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
ProPhase Labs
PRPH
|
53.1 M | - | - | $ 5.07 M |  USA |
 |
Endo International plc
ENDP
|
539 M | - | - | $ 28.9 M |  Irlanda |
 |
Evoke Pharma
EVOK
|
10.4 M | - | - | $ 36.6 M | USA |
 |
AcelRx Pharmaceuticals
ACRX
|
3.81 M | - | 7.5 % | $ 6.35 M | USA |
 |
DURECT Corporation
DRRX
|
7.71 M | - | - | $ 50.1 M | USA |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
11.4 M | - | 0.86 % | $ 117 M | USA |
 |
Aerie Pharmaceuticals
AERI
|
125 M | - | - | $ 754 M | USA |
 |
Agile Therapeutics
AGRX
|
20.8 M | - | 10.11 % | $ 58.2 M | USA |
 |
Alimera Sciences
ALIM
|
21.9 M | - | - | $ 142 M | USA |
 |
Athenex
ATNX
|
115 M | - | -23.39 % | $ 1.76 M | USA |
 |
Avadel Pharmaceuticals plc
AVDL
|
48.8 M | - | - | $ 2.06 B |  France |
 |
Catalent
CTLT
|
1.03 B | - | - | $ 11.5 B | USA |
 |
Sonoma Pharmaceuticals
SNOA
|
4.83 M | $ 1.14 | -1.72 % | $ 1.92 M | USA |
 |
Eagle Pharmaceuticals
EGRX
|
111 M | - | -39.89 % | $ 27.7 M | USA |
 |
Cronos Group
CRON
|
48.2 M | $ 2.81 | 2.55 % | $ 1.08 B |  Canada |
 |
TherapeuticsMD
TXMD
|
4.78 M | $ 2.06 | - | $ 23.8 M | USA |
 |
Jupiter Wellness
JUPW
|
5.98 M | - | - | $ 33.6 M | USA |
 |
Lannett Company
LCI
|
105 M | - | 1.15 % | $ 7.11 M | USA |
 |
Canopy Growth Corporation
CGC
|
158 M | $ 0.89 | -1.82 % | $ 265 M | Canada |
 |
Cumberland Pharmaceuticals
CPIX
|
36.7 M | $ 6.61 | -5.37 % | $ 98.2 M | USA |
 |
Neoleukin Therapeutics
NLTX
|
16.4 M | - | - | $ 193 M | Canada |
 |
Assertio Holdings
ASRT
|
128 M | - | - | $ 150 M | USA |
 |
Radius Health
RDUS
|
94.8 M | - | - | $ 1.42 B | USA |
 |
Recro Pharma
REPH
|
50 M | - | -4.76 % | $ 65.3 M | USA |
 |
OptiNose
OPTN
|
163 M | - | - | $ 1.08 B | USA |
 |
PLx Pharma
PLXP
|
11.9 M | - | -27.8 % | $ 2.56 M | USA |
 |
Zynerba Pharmaceuticals
ZYNE
|
9.17 M | - | - | $ 55.5 M | USA |
 |
Zomedica Corp.
ZOM
|
9.45 M | - | -0.21 % | $ 98 M | USA |
 |
Tricida
TCDA
|
29.5 M | - | - | $ 3.25 M | USA |
 |
Perrigo Company plc
PRGO
|
1.01 B | $ 10.09 | -0.1 % | $ 1.4 B | USA |
 |
Bausch Health Companies
BHC
|
4.18 B | $ 4.43 | -0.45 % | $ 1.64 B | Canada |
 |
Emergent BioSolutions
EBS
|
132 M | $ 7.26 | -3.2 % | $ 388 M | USA |
 |
China Pharma Holdings
CPHI
|
7.4 M | $ 1.52 | -18.28 % | $ 6.52 M |  China |
 |
Harrow Health
HROW
|
96.3 M | $ 38.45 | -8.19 % | $ 1.41 B | USA |
 |
SCYNEXIS
SCYX
|
5.73 M | $ 3.73 | -5.81 % | $ 186 M | USA |
 |
Evolus
EOLS
|
75.3 M | $ 5.98 | -0.17 % | $ 386 M | USA |
 |
Rockwell Medical
RMTI
|
9.58 M | $ 6.63 | 1.61 % | $ 239 M | USA |
 |
Solid Biosciences
SLDB
|
33.5 M | $ 7.83 | -1.88 % | $ 685 M | USA |
 |
Relmada Therapeutics
RLMD
|
6.43 M | $ 5.18 | -0.38 % | $ 205 M | USA |
 |
Veru
VERU
|
7.79 M | $ 2.25 | -2.6 % | $ 33 M | USA |
 |
Organogenesis Holdings
ORGO
|
100 M | $ 2.39 | -1.65 % | $ 303 M | USA |
 |
Pacira BioSciences
PCRX
|
310 M | $ 25.88 | -0.19 % | $ 1.2 B | USA |
 |
cbdMD
YCBD
|
3.19 M | $ 0.54 | -6.6 % | $ 2.17 M | USA |
 |
Tilray
TLRY
|
433 M | $ 3.88 | -2.76 % | $ 2.4 B | Canada |